Registry and biospecimen collection for synovial sarcoma patients
Synovial Sarcoma Registry and Biospecimen Repository
This study is collecting medical information and samples from people with synovial sarcoma to help researchers find better treatments and improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Children's Hospital of Philadelphia Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT05910307 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and store data and biological samples from patients diagnosed with synovial sarcoma to facilitate future research aimed at improving patient outcomes. Participants will provide access to their medical records, leftover tumor tissue, and may also give blood or saliva samples. They will complete questionnaires about their medical history and may be contacted periodically for updates over a span of up to 10 years. Genetic testing will be performed on the collected samples to explore potential insights into the disease.
Who should consider this trial
Good fit: Ideal candidates include individuals of any age with a confirmed diagnosis of synovial sarcoma who are willing to provide informed consent.
Not a fit: Patients with sarcomas that do not meet the criteria for this registry or those unwilling to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with synovial sarcoma.
How similar studies have performed: Other studies involving biorepositories and genetic testing in cancer have shown promise in advancing treatment options, indicating that this approach is both relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Males or females of any age 2. Reported diagnosis of synovial sarcoma 3. Informed consent from subject (aged ≥18 years) or parent/guardian Exclusion Criteria: 1. Individuals with sarcomas that do not fit the definition of those considered for this registry 2. Individuals who are unwilling to participate 3. Individuals who are unwilling or unable to provide written consent
Where this trial is running
Philadelphia, Pennsylvania
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Theodore Laetsch, MD — Children's Hospital of Philadelphia
- Study coordinator: Lauren Gutstein
- Email: gutsteinl1@chop.edu
- Phone: 267-425-2029
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.